Navigation Links
Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
Date:5/5/2008

MOUNTAIN VIEW, Calif., May 5 /PRNewswire/ -- Cardiva Medical, Inc., a privately held medical device company, announced today it has closed a $15.5 million private equity financing lead by PTV Sciences. Also investing in this financing were existing investors Galen Partners, Sycamore Ventures, Amkey Ventures, Lexli Investment, and Eminent Venture Capital. Cardiva intends to use the proceeds of the financing for general corporate purposes, including the expansion of its U.S. sales force.

Cardiva also announced that Mr. Rick Anderson, a Managing Director with PTV Sciences will join Cardiva's Board of Directors. Prior to PTV Sciences, Mr. Anderson served as Company Group Chairman, Johnson & Johnson, and Worldwide Franchise Chairman, Cordis Corporation. He was a key architect behind the launch of the world's first drug-eluting stent the CYPHER(R) Sirolimus-eluting Coronary Stent.

"We are delighted that PTV Sciences has joined with Cardiva's current investors to finance the expansion of our direct sales force in the U.S.," said Augustine Lien, Chairman and CEO. "We now have the resources to aggressively expand our customer base. We are also extremely pleased that Rick Anderson is joining our Board of Directors as his experience is ideally suited to assist Cardiva's expansion in the U.S. cardiology market."

"We are extremely excited about Cardiva's growth prospects," commented Rick Anderson. "Cardiva represents an outstanding opportunity to improve patient care by allowing patients to be discharged from the hospital faster without the complications usually associated with vascular closure devices, especially in interventional cardiology."

About Cardiva Medical, Inc.

Founded in July 2002, and headquartered in Mountain View, Calif., Cardiva Medical, Inc. is a privately held medical device company focused on developing and commercializing devices which close the vascular access site with unsurpassed safety and ease-of-use. Cardiva's f
'/>"/>

SOURCE Cardiva Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
4. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
5. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
6. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
7. Medical, Behavioral Woes Can Drive Dogs to Bite
8. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
9. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
10. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
11. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... children and adolescents with seizures involving the temporal ... problems and psychiatric illness, especially depression. Findings published ... Wiley on behalf of the International League Against ... evaluation for pediatric epilepsy patientsparticularly for those who ... epilepsy surgery. , Current medical evidence indicates ...
(Date:5/23/2013)... 23, 2013 CareAnyware , ... health and hospice software solutions, and Cornell University ... showed significant reductions in rehospitalization rates for clinically ... Carepath protocol incorporated into CareAnyware’s EMR system. Based ... which included a 39% reduction in rehospitalization rates ...
(Date:5/23/2013)... Lotus Valve, a second-generation transcatheter aortic valve implantation ... the first 60 patients in results from REPRISE ... device performance and low mortality at 30 days., ... but there are opportunities for improvement," explained lead ... and Professor of Medicine, Monash University, Melbourne, Australia. ...
(Date:5/23/2013)... Diego, CA (PRWEB) May 23, 2013 ... Medicus Ltd. (ASX: PME), announced today that they ... available on the Apple App Store*. When used in ... Platform, Visage Ease provides authorized healthcare providers simple mobile ... Touch iOS devices. , In addition to numerous enhancements ...
(Date:5/23/2013)... 2013 Registered Dietitian and Founder of ... today on Tatalou.com offering helpful tips for travelers who ... titled “ How to Stay Healthy While Traveling ,” ... sanitizer, when it’s safe to drink the water when ... importance of staying hydrated and how taking health supplements ...
Breaking Medicine News(10 mins):Health News:Depression common among children with temporal lobe epilepsy 2Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 2Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 3Health News:Second-generation TAVI device -- Lotus Valve -- shows good performance in REPRISE II 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 3Health News:How to Stay Healthy While Traveling 2
... and Rainbow,Kitchen Community Services announced today that they ... Against Hunger" on Saturday, April 26, 2008.,The event ... and services, and raises public awareness about the,benefits ... participants can either walk or ride bicycles,along the ...
... April 24 Prime Therapeutics (Prime), a,thought leader ... RPh, has joined the organization as Vice President ... Pharmacy Trade Relations, Wan will focus on,developing and ... Prime,s efforts in the development of strategic pharmacy,contracts ...
... Frankfurt: I7VF), INVERNESS, Scotland, April 24 /PRNewswire-FirstCall/ - ... sheet restructuring,leaving it free of all loan note indebtedness, ... to enable it to move forward. The Company has,been ... 2005., Medical Diagnostic Innovations Ltd, a UK investment ...
... (Nasdaq: STAA ) today announced that it will ... 2008 on Tuesday, May 6, 2008,after the market close. ... Tuesday, May 6, 2008 at 5:00 p.m. Eastern Time ... The dial-in number for,the conference call is 866-250-3615 for ...
... 24 The Quigley,Corporation (Nasdaq: QGLY ) today ... the first quarter ended March 31, 2008,compared to $6.1 ... The first quarter of 2008 reflects a net sales ... compared to the first quarter,of 2007. The change during ...
... ) announced that it will release first quarter 2008,financial results on Thursday, ... The Company will host a conference call to discuss the first ... First Quarter 2008 Earnings Conference Call, ... Thursday, May 1, 2008 at 5:00 p.m. Eastern Time, Dial-in: ...
Cached Medicine News:Health News:UPMC Health Plan and Rainbow Kitchen Community Services at 'W.A.R.' to Wipe Out Hunger in Pittsburgh 2Health News:UPMC Health Plan and Rainbow Kitchen Community Services at 'W.A.R.' to Wipe Out Hunger in Pittsburgh 3Health News:IVMD Inc. Announces Fundamental Balance Sheet Restructuring. 2Health News:IVMD Inc. Announces Fundamental Balance Sheet Restructuring. 3Health News:STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 3Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 4Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 5
(Date:5/22/2013)... 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), ... today that the Company will present at the Stifel Dental ... the Le Parker Meridian hotel, 119 W. 56 th ... presentation is scheduled to begin at 2:15 p.m. Eastern Time ... Heska Corporation (NASDAQ: HSKA - News) sells ...
(Date:5/22/2013)... Conn. , May 22, 2013 /PRNewswire-iReach/ -- ... stay aligned with the latest trends and events, ... that can predict where an industry is headed ... evolve. (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... partnership with market research publisher GlobalData, offer decision ...
(Date:5/22/2013)... May 22, 2013   Accuray Incorporated (Nasdaq: ... is scheduled to present at the 2013 Jefferies Global ... on Thursday, June 6, 2013 at 1:30 p.m. EDT/10:30 ... presentation will be available online from the Investor Relations ... The webcast replay of the presentation will begin ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4
... 15 Researchers at the Barbara,Ann Karmanos Cancer ... developed a HER2 DNA vaccine that has shown ... The study was reported in the September 15 ... Association for Cancer,Research., ( http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELO ,GO), ...
... women each year than all cancers combined. Although ... patients, the,unique risk factors and symptoms of female ... disease particularly challenging., Data from the WOMEN ... in WomeN presented today at the American Society ...
Cached Medicine Technology:DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers 2What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study 2
The ArthroPasser easily passes any type of suture through tissue and its smooth jaw assists in eliminating,suture fraying....
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
85 right angled suture passer....
45 right angled suture passer....
Medicine Products: